₹1.5 Lakh Per Dose: Inside India’s ‘Magic’ Cancer Drug Leak and Fake Market

A life-saving cancer drug, often described as a 'miracle' in modern oncology, is now at the centre of a disturbing crisis in India, one that blends medical innovation with criminal exploitation. At the heart of this story is Keytruda (pembrolizumab), an advanced immunotherapy drug that has transformed treatment outcomes for several aggressive cancers, from lung and cervical cancer to melanoma. But its promise comes at a staggering price. Each 100 mg vial costs over ₹1.5 lakh, pushing monthly treatment expenses beyond ₹3 lakh for many patients. This steep cost has inadvertently created fertile ground for a dangerous black market, one that preys on desperation.An investigation has revealed a complex network involving pharmacists, middlemen, and even

possible links within hospital systems. Genuine drugs are allegedly diverted from top hospitals and reintroduced into illegal supply chains. What makes this racket especially alarming is its sophistication: counterfeiters reportedly reuse original packaging, replicate batch numbers, and refill used vials, making fake drugs nearly indistinguishable from authentic ones. In one shocking case, a cancer patient’s family spent nearly ₹16 lakh on what they believed were discounted vials of the drug, only to later discover that the injections contained antifungal medication instead of the actual cancer treatment. By then, the damage, both financial and medical, had already been done.

Interstate Drug Rackets

The problem is not isolated. Investigations across multiple states have uncovered interstate rackets dealing in high-value oncology drugs, often using fake invoices, shell companies, and improper storage methods that further degrade drug effectiveness. In some cases, drugs marked 'Not for Sale' and intended for government supply have been repackaged and sold at full price in the open market. From a healthcare perspective, the risks are severe. Unlike standard medicines, immunotherapy drugs like Keytruda work by activating the body’s immune system to target cancer cells. When counterfeit versions are used, patients not only lose precious treatment time but may also experience disease progression without realizing the therapy is ineffective.Experts say the root causes of this crisis lie in a combination of high drug prices, limited accessibility, and gaps in supply chain monitoring. India’s cancer burden is rising rapidly, with cases expected to increase significantly in the coming decades, intensifying demand for such therapies. Law enforcement agencies have begun cracking down, with multiple arrests and seizures reported in recent months. However, the scale of the problem suggests a deeply entrenched network that requires stronger regulatory oversight, better hospital inventory tracking, and stricter penalties for offenders.

For Loved Ones

For patients and families, the takeaway is sobering: in the pursuit of life-saving treatment, vigilance is critical. Purchasing medicines only through verified hospital channels and avoiding 'discounted' deals outside authorised systems can be the difference between effective care and a dangerous scam. In a system where hope already comes at a high cost, the emergence of fake cancer drugs turns that hope into a potentially fatal gamble.